GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
Phase 1 Unknown
68 enrolled
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Unknown
77 enrolled
A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer
Phase 1 Unknown
8 enrolled
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Phase 1 Unknown
30 enrolled
NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer
Phase 1 Unknown
38 enrolled
A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.
Phase 1 Unknown
75 enrolled
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors
Phase 1 Unknown
36 enrolled
Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma
Phase 1 Unknown
48 enrolled
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors
Phase 1 Unknown
48 enrolled
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
Phase 1 Unknown
78 enrolled
A Study of IBI351 in Combination With Cetuximab in Subjects With KRAS G12C Mutated Metastatic Colorectal Cancer
Phase 1 Unknown
80 enrolled
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
Phase 1 Unknown
100 enrolled
Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients
Phase 1 Unknown
230 enrolled
Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
Phase 1 Unknown
33 enrolled
A Phase 1,Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
Phase 1 Unknown
80 enrolled
Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors
Phase 1 Unknown
60 enrolled
A Clinical Trial of TAA06 Injection in Advanced Solid Tumors
Phase 1 Unknown
18 enrolled
A Study to Investigate Safety and Tolerability of SH3809 Tablet in Patients With Advanced Solid Tumors
Phase 1 Unknown
55 enrolled
Study of the Safety and Effectiveness of HIFU Combined With REGOTORI for Metastatic Colorectal Cancer
Phase 1 Unknown
10 enrolled
Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer
Phase 1 Unknown
21 enrolled
Elucidation of the Mechanisms and Effects of Certain Anesthetic Interventions on Digestive Cancer Patients Subjected to Surgery
Phase 1 Unknown
40 enrolled
NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors
Phase 1 Unknown
10 enrolled
A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors
Phase 1 Unknown
90 enrolled
The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer
Phase 1 Unknown
33 enrolled
Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC
Phase 1 Unknown
60 enrolled
A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC
Phase 1 Unknown
18 enrolled
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
Phase 1 Unknown
10 enrolled
COTI2-101
Phase 1 Unknown
51 enrolled
A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
Phase 1 Unknown
21 enrolled
EGFRCART
Phase 1 Unknown
20 enrolled
Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810
Phase 1 Unknown
60 enrolled
A Clinical Research of CAR T Cells Targeting CEA Positive Cancer
Phase 1 Unknown
75 enrolled
Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal Cancer
Phase 1 Unknown
18 enrolled
Dendritic Killer Cell-based Immunotherapy for Solid Tumors
Phase 1 Unknown
18 enrolled
Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer
Phase 1 Unknown
72 enrolled
A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer
Phase 1 Unknown
36 enrolled
Safety, Tolerability and Pharmacokinetics of Recombinant Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
Phase 1 Unknown
21 enrolled
Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients
Phase 1 Unknown
15 enrolled
Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy
Phase 1 Unknown
30 enrolled
Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery
Phase 1 Unknown
30 enrolled
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
Phase 1 Unknown
50 enrolled
SU006668 in Treating Patients With Advanced Solid Tumors
Phase 1 Unknown
Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer
Phase 1 Unknown
Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer
Phase 1 Unknown
9 enrolled
Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer
Phase 1 Unknown
sutent-capiri
Phase 1 Unknown
32 enrolled
Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal Cancer
Phase 1 Unknown
20 enrolled
Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer
Phase 1 Unknown
15 enrolled
Cardiac Safety Assessment Study of Picoplatin in Solid Tumors
Phase 1 Unknown
40 enrolled
TIROX
Phase 1 Unknown
23 enrolled